Alison B Fleming - Net Worth and Insider Trading
Alison B Fleming Net Worth
The estimated net worth of Alison B Fleming is at least $5 Million dollars as of 2024-11-09. Alison B Fleming is the Chief Technical Officer of Collegium Pharmaceutical Inc and owns about 148,753 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $5 Million. Details can be seen in Alison B Fleming's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alison B Fleming has not made any transactions after 2021-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alison B Fleming
Alison B Fleming Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alison B Fleming owns 1 companies in total, including Collegium Pharmaceutical Inc (COLL) .
Click here to see the complete history of Alison B Fleming’s form 4 insider trades.
Insider Ownership Summary of Alison B Fleming
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2021-03-01 | Vice President & Product Devlp |
Alison B Fleming Latest Holdings Summary
Alison B Fleming currently owns a total of 1 stock. Alison B Fleming owns 148,753 shares of Collegium Pharmaceutical Inc (COLL) as of March 1, 2021, with a value of $5 Million.
Latest Holdings of Alison B Fleming
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2021-03-01 | 148,753 | 32.16 | 4,783,896 |
Holding Weightings of Alison B Fleming
Alison B Fleming Form 4 Trading Tracker
According to the SEC Form 4 filings, Alison B Fleming has made a total of 4 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 18,235 shares on March 1, 2021, which brought Alison B Fleming around $412,111.
Insider Trading History of Alison B Fleming
- 1
Alison B Fleming Trading Performance
Alison B Fleming Ownership Network
Ownership Network List of Alison B Fleming
Ownership Network Relation of Alison B Fleming
Alison B Fleming Owned Company Details
What does Collegium Pharmaceutical Inc do?
Who are the key executives at Collegium Pharmaceutical Inc?
Alison B Fleming is the Vice President & Product Devlp of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Financial Officer Tupper Colleen .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Alison B Fleming made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .
In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Collegium Pharmaceutical Inc Insider Transactions
Alison B Fleming Mailing Address
Above is the net worth, insider trading, and ownership report for Alison B Fleming. You might contact Alison B Fleming via mailing address: 780 Dedham Street, Suite 800, Canton Ma 02021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
